DE69808938D1 - Verfahren zur herstellung von pharmazeutischen zusammensetzungen - Google Patents

Verfahren zur herstellung von pharmazeutischen zusammensetzungen

Info

Publication number
DE69808938D1
DE69808938D1 DE69808938T DE69808938T DE69808938D1 DE 69808938 D1 DE69808938 D1 DE 69808938D1 DE 69808938 T DE69808938 T DE 69808938T DE 69808938 T DE69808938 T DE 69808938T DE 69808938 D1 DE69808938 D1 DE 69808938D1
Authority
DE
Germany
Prior art keywords
formulation
pharmacologically
acceptable
pharmaceutical compositions
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69808938T
Other languages
English (en)
Other versions
DE69808938T2 (de
Inventor
Seshagiri Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chauvin Pharmaceuticals Ltd
Original Assignee
Chauvin Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chauvin Pharmaceuticals Ltd filed Critical Chauvin Pharmaceuticals Ltd
Application granted granted Critical
Publication of DE69808938D1 publication Critical patent/DE69808938D1/de
Publication of DE69808938T2 publication Critical patent/DE69808938T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
DE69808938T 1997-09-03 1998-09-02 Verfahren zur herstellung von pharmazeutischen zusammensetzungen Expired - Fee Related DE69808938T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718568.0A GB9718568D0 (en) 1997-09-03 1997-09-03 Compositions
PCT/GB1998/002637 WO1999011239A1 (en) 1997-09-03 1998-09-02 Method for preparing pharmaceutical formulations

Publications (2)

Publication Number Publication Date
DE69808938D1 true DE69808938D1 (de) 2002-11-28
DE69808938T2 DE69808938T2 (de) 2003-07-03

Family

ID=10818388

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69808938T Expired - Fee Related DE69808938T2 (de) 1997-09-03 1998-09-02 Verfahren zur herstellung von pharmazeutischen zusammensetzungen

Country Status (11)

Country Link
US (1) US6379692B1 (de)
EP (1) EP1009380B1 (de)
JP (1) JPH11228386A (de)
AT (1) ATE226428T1 (de)
AU (1) AU741609B2 (de)
CA (1) CA2301325A1 (de)
DE (1) DE69808938T2 (de)
DK (1) DK1009380T3 (de)
ES (1) ES2186207T3 (de)
GB (2) GB9718568D0 (de)
WO (1) WO1999011239A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002015878A1 (en) * 2000-08-25 2002-02-28 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations
WO2002026234A1 (fr) * 2000-09-29 2002-04-04 Wakamoto Pharmaceutical Co., Ltd. Gouttes ophtalmiques contenant une suspension d'aciclovir
US20040105889A1 (en) * 2002-12-03 2004-06-03 Elan Pharma International Limited Low viscosity liquid dosage forms
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
PL215579B1 (pl) * 2002-04-19 2013-12-31 Novartis Ag Sposób otrzymywania osadu, osad otrzymany tym sposobem, kompozycja farmaceutyczna i wyrób medyczny
JP4512700B2 (ja) * 2003-06-02 2010-07-28 トーアエイヨー株式会社 アシクロビル含有水溶液製剤
KR101131056B1 (ko) * 2003-06-13 2012-04-23 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
WO2005099713A2 (es) * 2004-04-05 2005-10-27 Laboratorios Liomont, S.A. De C.V. Nueva presentación de una composición farmacéutica antiviral
US20060058390A1 (en) * 2004-09-14 2006-03-16 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
IE51421B1 (en) 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
GB2217595B (en) 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.
FR2679135B1 (fr) 1991-07-18 1995-05-19 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
WO1993017664A1 (en) 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
SE9401108D0 (sv) 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
JPH08268892A (ja) 1995-03-30 1996-10-15 Yuuwa Shoji:Kk 水溶液製剤及びその製造方法
GB2306885B (en) 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions
WO1998043643A1 (fr) * 1997-04-01 1998-10-08 Toa Medicine Co., Ltd. Preparations d'une solution aqueuse d'acyclovir

Also Published As

Publication number Publication date
DE69808938T2 (de) 2003-07-03
JPH11228386A (ja) 1999-08-24
GB9718568D0 (en) 1997-11-05
AU8878298A (en) 1999-03-22
US6379692B1 (en) 2002-04-30
EP1009380A1 (de) 2000-06-21
EP1009380B1 (de) 2002-10-23
GB9818973D0 (en) 1998-10-21
GB2328872A (en) 1999-03-10
ES2186207T3 (es) 2003-05-01
AU741609B2 (en) 2001-12-06
CA2301325A1 (en) 1999-03-11
WO1999011239A1 (en) 1999-03-11
GB2328872B (en) 2002-04-03
DK1009380T3 (da) 2003-02-24
ATE226428T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
EP1077070A3 (de) Orale Darreichungsform
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
FI950319A (fi) Säädellyn vapautumisnopeuden omaava morfiinivalmiste
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
GB9116610D0 (en) Preparation of microparticles
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
ATE208612T1 (de) Biologisch erodierbare vorrichtung zur verabreichung von wirkstoffen
ATE226428T1 (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
CA2284774A1 (en) Theobromine antitussive compositions
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
ATE126052T1 (de) System zur gesteuerten freisetzung von wirkstoffen sowie verfahren zu dessen herstellung.
KR910015297A (ko) 오메프라졸 경구용 약제와 그 제조방법
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IE61287B1 (en) Pharmaceutical composition for the transdermal application of herparin

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee